GAL-005

N/A

Report date: 2025/09/25 17:33:10

Base Information

Drug NameGAL-005
Drug Alias NameGAL005
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionGABA receptors modulators
TargetsGABA receptors
Therapy Area/IndicationsSuccinic semialdehyde dehydrogenase deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGalibra Neuroscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesGalibra Neuroscience Inc
Inactive CompaniesN/A
Active IndicationsSuccinic semialdehyde dehydrogenase deficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A